A nurse is caring for Mr. Thompson, a 62-year-old male with tumor lysis syndrome experiencing severe hyperkalemia. What is the priority nursing intervention to address his current condition?

A) Administer calcium gluconate to stabilize cardiac membrane excitability.

B) Increase oral hydration to facilitate renal excretion of potassium.

C) Administer sodium bicarbonate to correct acidosis and facilitate potassium shift into cells.

D) Encourage ambulation to enhance circulation and promote renal perfusion.

A 62-year-old male with tumor lysis syndrome is showing signs of worsening hyperkalemia and hypocalcemia. Despite initial management, his clinical status is deteriorating, and he is experiencing muscle cramps, tingling sensations, and ECG changes. Which of the following interventions should the nurse prioritize to stabilize the patient's condition?

A) Administer calcium gluconate intravenously to stabilize the cardiac membrane.

B) Increase oral fluid intake to enhance renal excretion of potassium.

C) Administer sodium bicarbonate to correct metabolic acidosis.

D) Provide oral phosphate binders to reduce serum phosphate levels.

A nurse is caring for Mr. Thompson who is experiencing worsening muscle cramps and a tingling sensation around his mouth and extremities. His laboratory results show elevated potassium levels and signs of hypocalcemia. Which of the following nursing interventions should be prioritized to address these findings?

A) Administer a potassium-sparing diuretic to help reduce potassium levels

B) Encourage increased oral fluid intake to enhance renal clearance

D) Implement a low-calcium diet to prevent calcium overload

Mr. Thompson is experiencing persistent hyperkalemia and worsening neuromuscular symptoms indicative of hypocalcemia. Which nursing intervention is most appropriate to prioritize in this situation to address his immediate safety needs?

C) Implement seizure precautions and closely monitor for signs of tetany or convulsions.

A) Encourage Mr. Thompson to increase his oral intake of water to promote diuresis.

B) Prepare the patient for continuous renal replacement therapy (CRRT) as ordered by the healthcare provider.

C) Implement seizure precautions and closely monitor for signs of tetany or convulsions.

D) Administer an additional dose of insulin and glucose to further lower potassium levels.

Mr. Thompson is undergoing continuous renal replacement therapy (CRRT) for tumor lysis syndrome and has developed metabolic acidosis. As the nurse caring for him, which intervention should be prioritized to address his current acid-base imbalance?

A) Increase the rate of CRRT to enhance clearance of acidic metabolites.

B) Administer sodium bicarbonate intravenously to correct the metabolic acidosis.

C) Monitor urine output hourly to assess kidney function improvement.

D) Increase oral fluid intake to promote natural renal clearance of acids.

Following the initiation of CRRT for Mr. Thompson, the nurse notes a gradual decrease in serum potassium levels but persistent metabolic acidosis. Which nursing intervention should be prioritized to address the metabolic imbalance?

C) Collaborate with the nephrologist to adjust the bicarbonate buffer prescription.

A) Increase the rate of CRRT to enhance clearance of acidic metabolites.

B) Administer calcium supplements to stabilize neuromuscular function.

C) Collaborate with the nephrologist to adjust the bicarbonate buffer prescription.

D) Encourage increased oral fluid intake to improve metabolic clearance.

A nurse is caring for Mr. Thompson, who is exhibiting signs of hypocalcemia and hyperphosphatemia. Despite current interventions, his condition requires further management. Which nursing intervention is most appropriate to prioritize in this situation to prevent further complications?

C) Increase the frequency of neuromuscular assessments and report any changes immediately.

A) Administer calcium supplements without adjusting the dosage of phosphate binders.

B) Monitor Mr. Thompson's respiratory status closely and prepare for potential respiratory support.

C) Increase the frequency of neuromuscular assessments and report any changes immediately.

D) Encourage Mr. Thompson to increase his physical activity to help reduce phosphate levels.

Mr. Thompson is experiencing hypocalcemia and hyperphosphatemia while on continuous renal replacement therapy (CRRT). Which nursing intervention is most appropriate to address these electrolyte imbalances and prevent complications?

D) Administer a phosphate binder with meals and monitor Mr. Thompson's serum phosphate and calcium levels closely.

A) Administer calcium gluconate intravenously as prescribed and monitor Mr. Thompson's cardiac rhythm.

B) Reduce the phosphate intake in Mr. Thompson's diet and encourage increased oral fluid intake.

C) Increase the rate of CRRT to enhance phosphate clearance and reduce the risk of calcium-phosphate precipitation.

D) Administer a phosphate binder with meals and monitor Mr. Thompson's serum phosphate and calcium levels closely.

Given Mr. Thompson's current clinical status and laboratory findings, which nursing intervention should be prioritized to address his risk of complications related to electrolyte imbalances?

B) Monitor neurological status closely and prepare to administer calcium gluconate if symptoms of tetany worsen

A) Encourage increased fluid intake to promote renal excretion of phosphate

B) Monitor neurological status closely and prepare to administer calcium gluconate if symptoms of tetany worsen

C) Educate the patient and family about the importance of adhering to a low-phosphate diet

D) Increase the frequency of vital signs monitoring to detect potential cardiac arrhythmias early

A nurse is caring for Mr. Thompson, who is experiencing fatigue and mild confusion following an increase in calcium supplementation. His calcium level has risen to 8.0 mg/dL, but his phosphate level remains elevated at 6.5 mg/dL. Considering these laboratory findings and clinical symptoms, what should be the nurse's priority intervention?

B) Administer a prescribed phosphate binder with meals.

A) Increase the frequency of neurological assessments to every two hours.

B) Administer a prescribed phosphate binder with meals.

C) Request an order to reduce the calcium supplementation.

D) Encourage high-phosphate foods to balance the calcium level.

Tumor lysis syndrome - Nursing Case Study

Pathophysiology

• Primary mechanism: Tumor lysis syndrome (TLS) occurs when rapid destruction of malignant cells releases large quantities of intracellular ions and metabolic byproducts into the bloodstream, overwhelming the body's excretory mechanisms.

• Secondary mechanism: The sudden surge of potassium, phosphate, and uric acid can lead to hyperkalemia, hyperphosphatemia, and hyperuricemia. Hyperkalemia can cause cardiac arrhythmias, while hyperphosphatemia can result in secondary hypocalcemia, leading to neuromuscular irritability and seizures.

• Key complication: The excess uric acid and calcium phosphate can precipitate in the renal tubules, causing acute kidney injury, which can exacerbate electrolyte imbalances and necessitate urgent medical intervention.

Patient Profile

Demographics:

62-year-old male, retired school teacher

History:

• Key past medical history: Hypertension, chronic kidney disease, diffuse large B-cell lymphoma

• Current medications: Losartan, Furosemide, Allopurinol, Rituximab

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and muscle cramps

• Key symptoms: Nausea, vomiting, decreased urine output, joint pain

• Vital signs: Blood pressure 100/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 37.6°C, oxygen saturation 93% on room air

Section 1

As the medical team continues monitoring Mr. Thompson, a 62-year-old male with a recent diagnosis of tumor lysis syndrome, they note a change in his clinical status. Despite initial management efforts, including hydration and administration of Allopurinol to prevent further uric acid buildup, Mr. Thompson's condition has begun to deteriorate. His muscle cramps have intensified, and he has developed tingling sensations around his mouth and extremities. Additionally, his nausea persists, and he remains oliguric, producing minimal urine output.

A repeat set of laboratory results reveals worsening hyperkalemia, with serum potassium now elevated at 6.5 mEq/L, and an increase in serum phosphate to 7.2 mg/dL, with a corresponding decrease in calcium to 7.0 mg/dL. His uric acid level remains elevated at 9.8 mg/dL. These abnormalities suggest an exacerbation of the electrolyte imbalances typically seen in tumor lysis syndrome, now contributing to neuromuscular irritability and increasing the risk for cardiac complications. Mr. Thompson's ECG shows peaked T-waves, a classic sign of hyperkalemia, underscoring the urgent need for further intervention to prevent life-threatening cardiac arrhythmias.

The healthcare team must now prioritize addressing these electrolyte disturbances. Potential interventions include administering calcium gluconate to stabilize the cardiac membrane, insulin and glucose to drive potassium back into the cells, and possible dialysis if renal function continues to decline. This evolving picture highlights the complexity of managing tumor lysis syndrome, requiring vigilant monitoring and timely interventions to mitigate the risk of severe complications and guide the patient towards stabilization.

Section 2

Mr. Thompson's condition continues to evolve, with the medical team closely monitoring his response to the interventions. After administering calcium gluconate, the team observes a temporary stabilization in his ECG readings, with a slight reduction in the peaked T-waves, indicating some improvement in his cardiac membrane stability. However, despite the administration of insulin and glucose, repeat potassium levels remain elevated at 6.2 mEq/L, highlighting the persistent challenge in managing his hyperkalemia. The nephrology team is consulted to discuss the initiation of dialysis, given Mr. Thompson's declining renal function, and the persistent oliguria, which suggests a worsening of acute kidney injury secondary to tumor lysis syndrome.

Concurrently, Mr. Thompson's neuromuscular symptoms have intensified. He reports worsening muscle cramps and an increase in the tingling sensation around his mouth and extremities, suggestive of hypocalcemia. A focused neurological assessment reveals slight hand twitching during blood pressure measurement, indicative of a positive Trousseau's sign, further pointing towards significant hypocalcemia. The nursing team implements safety precautions to prevent potential complications from neuromuscular irritability, such as falls or seizures, and communicates these changes to the medical team for urgent review and adjustment of the treatment plan.

In response to these developments, the healthcare team decides to initiate continuous renal replacement therapy (CRRT) to more effectively manage Mr. Thompson's electrolyte imbalances and support his renal function. This decision is made based on the continued presence of refractory hyperkalemia, hyperphosphatemia, and oliguric status, despite initial medical management. As the team prepares Mr. Thompson for CRRT, they reinforce the importance of close monitoring and regular reassessment of his laboratory values and clinical status. This intervention marks a critical step in addressing the complex interplay of factors contributing to his condition, with the hope of stabilizing him and preventing further complications.

Section 3

Following the initiation of continuous renal replacement therapy (CRRT), Mr. Thompson's clinical status undergoes further evaluation. The nursing team notes a slight improvement in his urine output, now measuring approximately 30 mL/hour, indicating a potential positive response to the renal support. However, his lab values show mixed results. While there is a gradual decrease in serum potassium levels to 5.5 mEq/L, suggesting some improvement in hyperkalemia management, his calcium levels remain critically low at 7.0 mg/dL, necessitating ongoing calcium supplementation and vigilant monitoring for neuromuscular symptoms.

Despite these interventions, Mr. Thompson's latest arterial blood gas analysis reveals a concerning development of metabolic acidosis, with a pH of 7.28 and bicarbonate level of 18 mEq/L. This shift suggests further deterioration in his metabolic state, likely due to the accumulation of organic acids from tumor lysis and renal impairment. As a result, the medical team decides to adjust the CRRT settings to optimize the clearance of acidic metabolites and improve acid-base balance, with the nephrologist recommending a modification in the bicarbonate buffer prescription.

Amid these changes, Mr. Thompson's vital signs remain stable, with blood pressure holding at 130/85 mmHg, heart rate at 88 beats per minute, and respirations at 20 breaths per minute. However, he continues to exhibit mild tachypnea, likely compensatory for the metabolic acidosis. The team discusses the importance of ongoing assessment and prompt adjustment of the treatment plan, emphasizing the need for regular evaluation of his neurological status and electrolyte levels to prevent further complications. This comprehensive approach aims to alleviate the acute manifestations of tumor lysis syndrome while supporting his overall recovery.

Section 4

As the team continues to monitor Mr. Thompson's progress, they note a new complication arising in his clinical picture. Despite the renal support and adjustments to the CRRT settings, Mr. Thompson begins to exhibit signs of hypocalcemia-related complications. During a routine neurological assessment, the nursing staff observes that Mr. Thompson has developed mild tetany, characterized by intermittent muscle spasms and increased neuromuscular irritability. This finding prompts further investigation into his calcium balance and the effectiveness of the ongoing supplementation regimen.

Simultaneously, the latest set of laboratory results reveals that, in addition to the persistent hypocalcemia, Mr. Thompson's phosphate levels have increased to 6.8 mg/dL, exacerbating the risk of calcium-phosphate precipitation and further complicating his electrolyte management. The nephrologist and nursing team discuss the implications of these findings and consider the need for additional interventions, such as phosphate binders, to control the hyperphosphatemia and support the calcium supplementation efforts. The team emphasizes the importance of closely monitoring Mr. Thompson's neuromuscular status and electrolyte levels, recognizing that any delay in addressing these imbalances could lead to more severe complications.

In light of these developments, the clinical team re-evaluates Mr. Thompson's treatment plan. They decide to intensify the frequency of laboratory evaluations to every four hours, allowing for more immediate adjustments to his therapy. The nephrologist also recommends increasing the calcium supplementation dosage, while carefully titrating it based on the serial calcium and phosphate levels. This proactive approach aims to stabilize his electrolyte balance, alleviate the neuromuscular symptoms, and prevent further complications associated with tumor lysis syndrome, ultimately supporting Mr. Thompson's path to recovery.

Section 5

As Mr. Thompson's treatment plan is adjusted, the nursing team remains vigilant in monitoring his response to the interventions. During one of the routine assessments following the enhanced calcium supplementation, the nursing staff notes a change in Mr. Thompson's status. Although his neuromuscular symptoms show slight improvement, with decreased frequency and intensity of the muscle spasms, he begins to exhibit signs of fatigue and mild confusion. His vital signs include a blood pressure of 100/68 mmHg, heart rate of 92 beats per minute, respiratory rate of 18 breaths per minute, and a temperature of 98.6°F. Despite these stable vital signs, his mental status change raises concerns about potential cerebral effects of the electrolyte imbalances.

The latest set of laboratory results indicates that Mr. Thompson's calcium level has risen to 8.0 mg/dL, suggesting a positive response to the increased supplementation. However, his phosphate level remains elevated at 6.5 mg/dL, indicating persistent hyperphosphatemia. Although the calcium-phosphate product has decreased slightly, it remains at a level that necessitates continued caution. The nephrologist and nursing team decide to start a phosphate binder regimen to further address the phosphate imbalance, hoping to mitigate the risk of calcium-phosphate precipitation and its potential complications. They also plan to reassess his cognitive status every four hours, correlating changes with lab results to ensure timely adjustments to the treatment plan.

As the clinical team implements these additional measures, they emphasize the importance of ongoing evaluation of Mr. Thompson's neurological status and laboratory values. They consider the potential for further complications, such as cardiac arrhythmias or worsening tetany, and prepare to intervene promptly should any arise. The team recognizes that Mr. Thompson's recovery hinges on a delicate balance of electrolytes, requiring continued collaboration and clinical reasoning to navigate the complexities of his condition and support his gradual return to stability.